3Van der Heijde DM, van't Hof M, van Riel PL, et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists[J]. J Rheumatol, 1993, 20(3): 579-581.
6Smigielska-Czepiel K, van den Berg A, Jellema P, et al. Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs[J]. Genes Immun, 2014, 15(2): 115-125.
7Chalan P, Kroesen B J, van der Geest KS, et al. Circulating CD4+CD161+ T lymphocytes are increased in seropositive arthralgia patients but decreased in patients with newly diagnosed rheumatoid arthritis[J]. PLoS One, 2013, 8(11): e79370.
6Shellekens GA, Visser H,de-jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic cirtnfllinated peptide [J]. Arthrtitis Rheum,2000,43(1): 155-163
7Vossenaar ER, Despres N,Lapointe E, et al. Rheumatoid arthritis specific anti-Sa antibodies target peptide antibody by B lympho-cytes in rheumatoid arthritis [J]. Arthrtitis Rest her,2004,6(2);R142-R150
8Reparon-Schuijt CC, van-Esch WJ.Secretion of anti-citrulline-containing peptide by B lymphocytes in rheumatoid arthritis[J].Arthrtitis Rheum,2001,44(1):41-47
9Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol, 2012, 130: 607-612.
